文献速递糖尿病肥胖与代谢综合征

肥胖患者接受减重手术或常规治疗后微血管疾病的长期发病率:按基线血糖状态分层的瑞典肥胖受试者研究的事后分析

Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2017-02-23

基于瑞典肥胖受试者(SOS)研究的事后分析,纳入4047名参与者中的4032人,比较减重手术组(n=2010)与常规治疗组(n=2037)的微血管疾病长期发病率。中位随访19年,手术组微血管疾病风险低于对照组(HR 0.56,95%CI 0.48-0.66;p<0.0001),基线血糖状态与治疗效果存在显著交互作用(p=0.0003)。

要点

  • 减重手术与微血管疾病风险降低相关(HR 0.56,95%CI 0.48-0.66)。
  • 基线血糖状态与手术效果存在显著交互作用(p=0.0003)。
  • 基线糖尿病前期亚组未调整HR最低(0.18,95%CI 0.11-0.30)。

核心结论

  • 减重手术与所有亚组微血管并发症风险降低相关,但基线糖尿病前期患者的相对风险降低幅度最大。
  • 结果提示应积极治疗糖尿病前期以预防未来微血管事件,并需为此开发有效的非手术疗法。

研究设计与样本

  • 瑞典肥胖受试者(SOS)研究的事后分析,1987年9月1日至2001年1月31日招募,年龄37-60岁,男性BMI≥34 kg/m²、女性BMI≥38 kg/m²。
  • 手术组n=2010接受胃旁路术(265例[13%])、胃束带术(376例[19%])或垂直束带胃成形术(1369例[68%]);对照组n=2037接受常规治疗。
  • 最终分析纳入4032人,排除疑似1型糖尿病4例及基线血糖状态未知11例。
  • 按基线血糖状态分为血糖正常(空腹血糖<5.0 mmol/L)、糖尿病前期(5.0-6.0 mmol/L)、筛查发现的糖尿病(基线访视时≥6.1 mmol/L且既往未诊断)和已确诊糖尿病(研究纳入前已诊断)。
  • 主要分析为意向性治疗分析,并按基线血糖状态及15年随访时糖尿病状态进行亚组分析。

主要发现

  • 中位随访19年(IQR 16-21),对照组发生374例微血管疾病,手术组发生224例(HR 0.56,95%CI 0.48-0.66;p<0.0001)。
  • 基线血糖状态与治疗对微血管疾病发病率的交互作用显著(p=0.0003)。
  • 未调整HR在糖尿病前期亚组最低(0.18,95%CI 0.11-0.30),其次为筛查发现的糖尿病亚组(0.39,95%CI 0.24-0.65)、已确诊糖尿病亚组(0.54,95%CI 0.40-0.72)和血糖正常亚组(0.63,95%CI 0.48-0.81)。
  • 在糖尿病前期人群中,无论随访期间是否发展为糖尿病,手术均与微血管事件发生率降低相关。

临床怎么用

  • 作者认为,糖尿病前期应积极治疗以预防未来微血管事件。
  • 作者建议,需要为此开发有效的非手术疗法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bariatric surgery is associated with remission of diabetes and prevention of diabetic complications in patients with obesity and type 2 diabetes. Long-term effects of bariatric surgery on microvascular complications in patients with prediabetes are unknown. The aim of this study was to examine the effects of bariatric surgery on incidence of microvascular complications in patients with obesity stratified by baseline glycaemic status. METHODS: Patients were recruited to the Swedish Obese Subjects (SOS) study between Sept 1, 1987, and Jan 31, 2001. Inclusion criteria were age 37-60 years and BMI of 34 kg/m2 or greater in men and 38 kg/m2 or greater in women. Exclusion criteria were identical in surgery and control groups and designed to exclude patients not suitable for surgery. The surgery group (n=2010) underwent gastric bypass (265 [13%]), gastric banding (376 [19%]), or vertical-banded gastroplasty (1369 [68%]). Participants in the control group (n=2037) received usual care. Bodyweight was measured and questionnaires were completed at baseline and at 0·5 years, 1 year, 2 years, 3 years, 4 years, 6 years, 8 years, 10 years, 15 years, and 20 years. Biochemical variables were measured at baseline and at 2 years, 10 years, and 15 years. We categorised participants into subgroups on the basis of baseline glycaemic status (normal [fasting blood glucose concentration <5·0 mmol/L], prediabetes [5·0-6·0 mmol/L], screen-detected diabetes [≥6·1 mmol/L at baseline visit without previous diagnosis], and established diabetes [diagnosis of diabetes before study inclusion]). We obtained data about first incidence of microvascular disease from nationwide registers and about diabetes incidence at study visits at 2 years, 10 years, and 15 years. We did the main analysis by intention to treat, and subgroup analyses after stratification by baseline glycaemic status and by diabetes status at the 15 year follow-up. The SOS study is registered with ClinicalTrials.gov, NCT01479452. FINDINGS: 4032 of the 4047 participants in the SOS study were included in this analysis. We excluded four patients with suspected type 1 diabetes, and 11 patients with unknown glycaemic status at baseline. At baseline, 2838 patients had normal blood glucose, 591 had prediabetes, 246 had screen-detected diabetes, and 357 had established diabetes. Median follow-up was 19 years (IQR 16-21). We identified 374 incident cases of microvascular disease in the control group and 224 in the surgery group (hazard ratio [HR] 0·56, 95% CI 0·48-0·66; p<0·0001). Interaction between baseline glycaemic status and effect of treatment on incidence of microvascular disease was significant (p=0·0003). Unadjusted HRs were lowest in the subgroup with prediabetes (0·18, 95% CI 0·11-0·30), followed by subgroups with screen-detected diabetes (0·39, 0·24-0·65), established diabetes (0·54, 0·40-0·72), and normoglycaemia (0·63, 0·48-0·81). Surgery was associated with reduced incidence of microvascular events in people with prediabetes regardless of whether they developed diabetes during follow-up. INTERPRETATION: Bariatric surgery was associated with reduced risk of microvascular complications in all subgroups, but the greatest relative risk reduction was observed in patients with prediabetes at baseline. Our results suggest that prediabetes should be treated aggressively to prevent future microvascular events, and effective non-surgical treatments need to be developed for this purpose. FUNDING: US National Institutes of Health, Swedish Research Council, Sahlgrenska University Hospital Regional Agreement on Medical Education and Research, and Swedish Diabetes Foundation.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Carlsson LMS, Sjöholm K, Karlsson C, et al. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2017. PMID: 28237791. doi:10.1016/S2213-8587(17)30061-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。